Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44393 clinical trials with a EudraCT protocol, of which 7405 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,393)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,393 result(s) found. Displaying page 1,707 of 2,220.

EudraCT Number: 2018-003523-11

Sponsor Protocol Number: CGP24112301

Start Date*: 2019-08-29

Sponsor Name:Hexal AG

Full Title: A randomized, double-blind, multicenter integrated phase I/III study in postmenopausal women with osteoporosis to compare the pharmacokinetics, pharmacodynamics, efficacy, safety and immunogenicity...

Medical condition: Osteoporosis is defined as a progressive, systemic skeletal disorder characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10028395 - Musculoskeletal and connective tissue disorders	10031282	Osteoporosis	PT
	20.0	10028395 - Musculoskeletal and connective tissue disorders	10031285	Osteoporosis postmenopausal	PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: CZ (Completed) ES (Completed) BG (Completed)

Trial results: View results

EudraCT Number: 2018-004926-26

Sponsor Protocol Number: PRV-031-001

Start Date*: 2019-11-21

Sponsor Name:Provention Bio, Inc.

Full Title: A Phase 3, Randomized, Double-Blind, Multinational, Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, anti-CD3 Monoclonal Antibody, in ...

Medical condition: Type 1 Diabetes (T1D)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004861	10012594	Diabetes	LLT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: HU (Completed) CZ (Completed) PL (Completed) DE (Completed) FR (Completed) FI (Ongoing) BE (Completed) GB (GB - no longer in EU/EEA)

Trial results: View results

EudraCT Number: 2018-002080-25

Sponsor Protocol Number: NBG-19-01

Start Date*: 2019-06-26

Sponsor Name:Skåne University Hospital

Full Title: A TRANSLATIONAL RANDOMIZED PHASE III STUDY EXPLORING THE EFFECT OF THE ADDITION OF CAPECITABINE TO CARBOPLATINUM BASED CHEMOTHERAPY IN EARLY “TRIPLE NEGATIVE” BREAST CANCER.

Medical condition: Early triple negative breast cancer.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006192	Breast cancer NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Trial now transitioned) DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2020-004137-21	Sponsor Protocol Number: 78591.041.21	Start Date*: 2021-10-28
Sponsor Name:University Medical Center Utrecht
Full Title: Effect of intranasal administration of palivizumab on experimental respiratory syncytial viral infection – a human challenge study
Medical condition: respiratory syncytial virus infection
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2021-006812-10

Sponsor Protocol Number: BBI-20201001

Start Date*: 2023-04-05

Sponsor Name:Bolt Biotherapeutics, Inc.

Full Title: Phase 1/2 Study of BDC 1001 as a Single Agent and in Combination with Nivolumab in Patients with Advanced HER2-Expressing Solid Tumors.

Medical condition: Advanced HER2-Expressing Solid Tumors

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.0	10010331 - Congenital, familial and genetic disorders	10075638	HER2 protein overexpression	PT
	23.0	10010331 - Congenital, familial and genetic disorders	10075653	HER2 gene amplification	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2020-003682-19	Sponsor Protocol Number: OxyPir1	Start Date*: 2020-12-18
Sponsor Name:UZ Brussel
Full Title: Post-operative patient controlled intravenous oxyco-done vs patient controlled intrav nous piritramide. A randomized controlled trial.
Medical condition: To determine whether oxycodone gives better postoperative pain relief (using VAS scores) than IV piritramide in abdominal and gynecological surgery.
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results

EudraCT Number: 2015-001282-13	Sponsor Protocol Number: AGO/2015/004	Start Date*: 2015-06-30
Sponsor Name:Ghent University Hospital
Full Title: Evaluation of acute normovolemic hemodilution on coagulation during liver surgery.
Medical condition: coagulation during liver surgery Acute normowolemic hemodilution
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results

EudraCT Number: 2019-001232-59

Sponsor Protocol Number: AGO/2019/002

Start Date*: 2020-01-29

Sponsor Name:Ghent University Hospital

Full Title: Safety and Efficacy of Patient Controlled Analgesia using the Sublingual Sufentanil Tablet System (SSTS) in a fast track rehabilitation program after Total Knee Arthroplasty.

Medical condition: Total Knee Arthroplasty

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10042613 - Surgical and medical procedures	10036276	Postoperative analgesia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2018-003687-31	Sponsor Protocol Number: AGO/2018/005	Start Date*: 2019-01-31
Sponsor Name:Ghent University Hospital
Full Title: Influence of continuous administration of phenylephrine versus dobutamine on spinal oxygen saturation, measured with near-infrared spectroscopy (NIRS).
Medical condition: spinal vasculature spinal oxygen saturation muscle oxygen saturation cerebral oxygen saturation
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results

EudraCT Number: 2020-005339-56

Sponsor Protocol Number: CQGE031G12301

Start Date*: Information not available in EudraCT

Sponsor Name:Novartis Pharma AG

Full Title: A 52 week, multi-center, randomized, double-blind placebo-controlled study to assess the clinical efficacy and safety of ligelizumab (QGE031) in decreasing the sensitivity to peanuts in patients wi...

Medical condition: Allergy, Peanut

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004870	10034202	Peanut allergy	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Prematurely Ended) ES (Ongoing) DE (Prematurely Ended) IT (Prematurely Ended) DK (Prematurely Ended) NL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2014-001005-41	Sponsor Protocol Number: fluresstudy	Start Date*: 2014-12-10
Sponsor Name:Ghent University Hospital
Full Title: Evaluation of FLuid REsuscitation with Sterofundin ® ISO (Ringerfundin), Plasma-Lyte® or NaCl 0.9%. (FluReS study)
Medical condition: hypovolemia-->need for fluid therapy
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results

EudraCT Number: 2012-002927-14

Sponsor Protocol Number: AGO/2012/004

Start Date*: 2013-07-10

Sponsor Name:University Ghent

Full Title: Dosistitratie van lisinopril bij kinderen van 1 tot 18 jaar met primaire of secundaire hypertensie

Medical condition: Hypertensie

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10047065 - Vascular disorders	10020781	Hypertension malignant	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2016-003998-17	Sponsor Protocol Number: ONCOGHdC2015-01	Start Date*: 2017-02-16
Sponsor Name:Grand Hôpital de Charleroi
Full Title: A phase Ib/II study of Durvalumab (MEDI4736) combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)
Medical condition: patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: (No results available)

EudraCT Number: 2019-001521-27

Sponsor Protocol Number: SP-1011-003

Start Date*: 2020-08-03

Sponsor Name:Adare Pharmaceuticals US, LP

Full Title: Fluticasone propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 in Adult and Adolescent Subjects w...

Medical condition: Eosinophilic Esophagitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004856	10064220	Eosinophilic esophagitis	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) ES (Completed)

Trial results: (No results available)

EudraCT Number: 2010-023168-41

Sponsor Protocol Number: 1248.6

Start Date*: 2011-10-17

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG,

Full Title: A randomised, double-blind, double-dummy, placebo-controlled, parallel-group study to assess and compare efficacy and safety of an 8-week treatment with BI 54903 at doses of 45.5, 90.9 and 181.8 μg...

Medical condition: Asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10003561	Asthma, unspecified	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) BG (Completed) FR (Ongoing) SK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2010-023169-23

Sponsor Protocol Number: 1248.7

Start Date*: Information not available in EudraCT

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG

Full Title: A randomised, double-blind, double-dummy, active-controlled, parallel-group study to assess and compare efficacy and safety of an 8-week treatment with BI 54903 at doses of 90.9 181.8 and 363.6 μg ...

Medical condition: Asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10003561	Asthma, unspecified	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: BG (Completed) DE (Prematurely Ended) FR (Ongoing) SK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2010-023167-17

Sponsor Protocol Number: 1248.5

Start Date*: 2011-10-13

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG,

Medical condition: Asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10003561	Asthma, unspecified	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) BG (Completed) FR (Ongoing) SK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2014-001561-27

Sponsor Protocol Number: 2000790

Start Date*: 2014-08-25

Sponsor Name:VU university medical center

Full Title: Vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia: comparing one-hour infusions with short-term infusions (the VINCA-study)

Medical condition: Pediatric oncology, acute lymphoblastic leukemia, nephroblastoma, medulloblastoma, low-grade glioma, Hodgkin lymphoma, rhabdomyosarcoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004864	10001690	ALL	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: NL (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2020-004910-37

Sponsor Protocol Number: OASIS-II

Start Date*: 2021-05-11

Sponsor Name:LYSARC

Full Title: A randomized phase II trial evaluating Ibrutinib plus CD20 Ab and Ibrutinib-Venetoclax plus CD20 Ab in patients with untreated mantle cell lymphoma

Medical condition: Untreated mantle cell lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061275	Mantle cell lymphoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned) BE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-003951-41	Sponsor Protocol Number: BFS-AS-40184	Start Date*: 2023-05-04
Sponsor Name:Teva Branded Pharmaceutical Products R&D, Inc.
Full Title: CONNected Electronic Inhalers Asthma Control Trial 3 (“CONNECT 3”), a 24-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison Study of Standard of Care Treatment Versus th...
Medical condition: Asthma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Prematurely Ended)
Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sun Apr 05 04:24:52 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA